FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166131657> ?p ?o ?g. }

• W2166131657 endingPage "1480" @default.
• W2166131657 startingPage "1476" @default.
• W2166131657 abstract "No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Nov 2000LONG-TERM RESULTS OF SACRAL NERVE STIMULATION (S3) FOR THE TREATMENT OF NEUROGENIC REFRACTORY URGE INCONTINENCE RELATED TO DETRUSOR HYPERREFLEXIA EMMANUEL J. CHARTIER-KASTLER, J.L. H. RUUD BOSCH, MICHEL PERRIGOT, MICHAEL B. CHANCELLOR, FRANÇOIS RICHARD, and PIERRE DENYS EMMANUEL J. CHARTIER-KASTLEREMMANUEL J. CHARTIER-KASTLER More articles by this author , J.L. H. RUUD BOSCHJ.L. H. RUUD BOSCH More articles by this author , MICHEL PERRIGOTMICHEL PERRIGOT More articles by this author , MICHAEL B. CHANCELLORMICHAEL B. CHANCELLOR Financial interest and/or other relationship with Afferon, Alza Pharmaceuticals, Medtronic, Pharmacia Upjohn and Situs, Inc. More articles by this author , FRANÇOIS RICHARDFRANÇOIS RICHARD Financial interest and/or other relationship with Lab Fabre, Fournier Debat, Ethicon and Boeringer Ingelheim. More articles by this author , and PIERRE DENYSPIERRE DENYS More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)67010-3AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We assess clinical and urodynamic results of sacral nerve stimulation for patients with neurogenic (spinal cord diseases) urge incontinence and detrusor hyperreflexia resistant to parasympatholytic drugs. Materials and Methods: Since 1992, 9 women with a mean age of 42.6 years (range 26 to 53) were treated for refractory neurogenic urge incontinence with sacral nerve stimulation. Neurological spinal diseases included viral and vascular myelitis in 1 patient each, multiple sclerosis in 5 and traumatic spinal cord injury in 2. Mean time since neurological diagnosis was 12 years. All patients had incontinence with chronic pad use related to detrusor hyperreflexia. Intermittent self-catheterization for external detrusor-sphincter dyssynergia was used by 5 patients. Social life was impaired and these patients were candidates for bladder augmentation. A sacral (S3) lead was surgically implanted and connected to a subcutaneous neurostimulator after a positive test stimulation trial. Results: Mean followup was 43.6 months (range 7 to 72). All patients had clinically significant improvement of incontinence, and 5 were completely dry. Average number of voids per day decreased from 16.1 to 8.2. Urodynamic parameters at 6 months after implant improved significantly from baseline, including maximum bladder capacity from 244 to 377 ml. and volume at first uninhibited contraction from 214 to 340 ml. Maximum detrusor pressure at first uninhibited contraction increased in 3, stabilized in 2 and decreased in 4 patients. Urodynamic results returned to baseline when stimulation was inactivated. All patients subjectively reported improved visual analog scale results by at least 75% at last followup. Conclusions: Sacral nerve stimulation can be used as a reversible treatment option for refractory urge incontinence related to detrusor hyperreflexia in select patients with spinal lesions. References 1 : Treatment of unstable bladder. Urology1991; 37: 28. Google Scholar 2 : Mechanism underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst1990; 30: S71. Google Scholar 3 : Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol1999; 57: 583. Google Scholar 4 : Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol1999; 162: 3. Link, Google Scholar 5 : The first 500 sacral anterior root stimulator implants: general description. Paraplegia1994; 32: 795. Google Scholar 6 : The treatment of incontinence by electronic implants: Hunterian Lecture delivered at the Royal College of Surgeons of England on 8th December 1966. Ann R Coll Surg Engl1967; 41: 447. Google Scholar 7 : Applications of neurostimulation in urology. Neurourol Urodyn1988; 7: 585. Google Scholar 8 : Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol1994; 152: 2071. Link, Google Scholar 9 : Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol1995; 154: 504. Link, Google Scholar 10 : S3 sacral neuromodulation in patients with chronic refractory miction disorders. Presse Med1997; 26: 466. Google Scholar 11 : Sacral nerve stimulation for treatment of refractory urinary urge incontinence. J Urol1999; 162: 352. Link, Google Scholar 12 : Standardization of terminology of lower urinary tract function. In: Clinical Neuro-Urology. Edited by . Boston: Little, Brown and Co.1991: 649. Appendix. Google Scholar 13 : Urodynamics. London: Springer-Verlag1997: 18. chapt. 3. Google Scholar 14 : Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am1992; 19: 163. Google Scholar 15 : Treatment of refractory urge incontinence with sacral spinal nerve stimulation in multiple sclerosis patients. Lancet1996; 348: 717. Google Scholar 16 : The effect of detrusor sphincter dyssynergia on neuromodulation in detrusor hyper-reflexia. Br J Urol1997; 79: 47. Google Scholar 17 : Detrusor inhibition induced by stimulation of pudendal nerve afferents. Neurourol Urodyn1986; 5: 381. Google Scholar 18 : Surgical principles of sacral foramen electrode implantation. World J Urol1991; 9: 133. Google Scholar 19 : Spinal pathways mediate coordinated bladder/urethral sphincter activity during reflex micturition in decerebrate and spinalized neonatal rats. Neurosci Lett1993; 152: 141. Google Scholar 20 : Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hyperflexia. Behav Brain Res1998; 92: 141. Google Scholar 21 : Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin North Am1991; 18: 393. Google Scholar 22 : Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol1999; 36: 81. Google Scholar From the Departments of Urology and Neurologic Rehabilitation, Pitié-Salpétrière Hospital, University Pierre et Marie Curie (Paris VI), Paris, Department of Neurological Rehabilitation, Raymond Poincaré Hospital, Université Paris-ouest, Garches, France, Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands, and Department of Urologic Surgery, Neuro-Urology and Urinary Incontinence Programs, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania© 2000 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byGroen J, Ruud Bosch J and van Mastrigt R (2018) Sacral Neuromodulation in Women With Idiopathic Detrusor Overactivity Incontinence: Decreased Overactivity but Unchanged Bladder Contraction Strength and Urethral Resistance During VoidingJournal of Urology, VOL. 175, NO. 3, (1005-1009), Online publication date: 1-Mar-2006.Staskin D (2018) Stimulating Aspects of Sacral Nerve StimulationJournal of Urology, VOL. 175, NO. 6, (1991-1992), Online publication date: 1-Jun-2006.ROUPRET M, CHARTIER-KASTLER E, ALMERAS C, AYOUB N, HAERTIG A and RICHARD F (2018) SACRAL NEUROMODULATION FOR REFRACTORY DETRUSOR OVERACTIVITY IN WOMEN WITH AN ARTIFICIAL URINARY SPHINCTERJournal of Urology, VOL. 172, NO. 1, (236-239), Online publication date: 1-Jul-2004.DIOKNO A, LEU P and KONSTANDT D (2018) A Simplified Method of Implanting a Neuromodulator DeviceJournal of Urology, VOL. 169, NO. 4, (1466-1469), Online publication date: 1-Apr-2003.WISEMAN O, HOMBERGH U, KOLDEWIJN E, SPINELLI M, SIEGEL S and FOWLER C (2018) SACRAL NEUROMODULATION AND PREGNANCYJournal of Urology, VOL. 167, NO. 1, (165-168), Online publication date: 1-Jan-2002.CAPPELLANO F, BERTAPELLE P, SPINELLI M, CATANZARO F, CARONE R, ZANOLLO A, DE SETA F and GIARDIELLO G (2018) QUALITY OF LIFE ASSESSMENT IN PATIENTS WHO UNDERGO SACRAL NEUROMODULATION IMPLANTATION FOR URGE INCONTINENCE: AN ADDITIONAL TOOL FOR EVALUATING OUTCOMEJournal of Urology, VOL. 166, NO. 6, (2277-2280), Online publication date: 1-Dec-2001. Volume 164Issue 5November 2000Page: 1476-1480 Advertisement Copyright & Permissions© 2000 by American Urological Association, Inc.Keywordsreflex, abnormalsacrumurinary incontinencebladder, neurogenicMetricsAuthor Information EMMANUEL J. CHARTIER-KASTLER More articles by this author J.L. H. RUUD BOSCH More articles by this author MICHEL PERRIGOT More articles by this author MICHAEL B. CHANCELLOR Financial interest and/or other relationship with Afferon, Alza Pharmaceuticals, Medtronic, Pharmacia Upjohn and Situs, Inc. More articles by this author FRANÇOIS RICHARD Financial interest and/or other relationship with Lab Fabre, Fournier Debat, Ethicon and Boeringer Ingelheim. More articles by this author PIERRE DENYS More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2166131657 created "2016-06-24" @default.
• W2166131657 creator A5004624271 @default.
• W2166131657 creator A5035860973 @default.
• W2166131657 creator A5041352205 @default.
• W2166131657 creator A5076037136 @default.
• W2166131657 creator A5078576293 @default.
• W2166131657 creator A5083119810 @default.
• W2166131657 date "2000-11-01" @default.
• W2166131657 modified "2023-10-18" @default.
• W2166131657 title "LONG-TERM RESULTS OF SACRAL NERVE STIMULATION (S3) FOR THE TREATMENT OF NEUROGENIC REFRACTORY URGE INCONTINENCE RELATED TO DETRUSOR HYPERREFLEXIA" @default.
• W2166131657 cites W2002406661 @default.
• W2166131657 cites W2003236086 @default.
• W2166131657 cites W2006345774 @default.
• W2166131657 cites W2013297373 @default.
• W2166131657 cites W2030384764 @default.
• W2166131657 cites W2030724327 @default.
• W2166131657 cites W2043209121 @default.
• W2166131657 cites W2054256968 @default.
• W2166131657 cites W2056065921 @default.
• W2166131657 cites W2056291238 @default.
• W2166131657 cites W2057369640 @default.
• W2166131657 cites W2093911461 @default.
• W2166131657 cites W2096869731 @default.
• W2166131657 cites W2130135725 @default.
• W2166131657 cites W2409919231 @default.
• W2166131657 cites W2464258360 @default.
• W2166131657 doi "https://doi.org/10.1016/s0022-5347(05)67010-3" @default.
• W2166131657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11025686" @default.
• W2166131657 hasPublicationYear "2000" @default.
• W2166131657 type Work @default.
• W2166131657 sameAs 2166131657 @default.
• W2166131657 citedByCount "150" @default.
• W2166131657 countsByYear W21661316572012 @default.
• W2166131657 countsByYear W21661316572013 @default.
• W2166131657 countsByYear W21661316572014 @default.
• W2166131657 countsByYear W21661316572015 @default.
• W2166131657 countsByYear W21661316572016 @default.
• W2166131657 countsByYear W21661316572017 @default.
• W2166131657 countsByYear W21661316572018 @default.
• W2166131657 countsByYear W21661316572019 @default.
• W2166131657 countsByYear W21661316572020 @default.
• W2166131657 countsByYear W21661316572021 @default.
• W2166131657 countsByYear W21661316572022 @default.
• W2166131657 countsByYear W21661316572023 @default.
• W2166131657 crossrefType "journal-article" @default.
• W2166131657 hasAuthorship W2166131657A5004624271 @default.
• W2166131657 hasAuthorship W2166131657A5035860973 @default.
• W2166131657 hasAuthorship W2166131657A5041352205 @default.
• W2166131657 hasAuthorship W2166131657A5076037136 @default.
• W2166131657 hasAuthorship W2166131657A5078576293 @default.
• W2166131657 hasAuthorship W2166131657A5083119810 @default.
• W2166131657 hasConcept C121332964 @default.
• W2166131657 hasConcept C126322002 @default.
• W2166131657 hasConcept C126894567 @default.
• W2166131657 hasConcept C142424586 @default.
• W2166131657 hasConcept C24998067 @default.
• W2166131657 hasConcept C2777364249 @default.
• W2166131657 hasConcept C2778531004 @default.
• W2166131657 hasConcept C2781036200 @default.
• W2166131657 hasConcept C42219234 @default.
• W2166131657 hasConcept C71924100 @default.
• W2166131657 hasConcept C87355193 @default.
• W2166131657 hasConceptScore W2166131657C121332964 @default.
• W2166131657 hasConceptScore W2166131657C126322002 @default.
• W2166131657 hasConceptScore W2166131657C126894567 @default.
• W2166131657 hasConceptScore W2166131657C142424586 @default.
• W2166131657 hasConceptScore W2166131657C24998067 @default.
• W2166131657 hasConceptScore W2166131657C2777364249 @default.
• W2166131657 hasConceptScore W2166131657C2778531004 @default.
• W2166131657 hasConceptScore W2166131657C2781036200 @default.
• W2166131657 hasConceptScore W2166131657C42219234 @default.
• W2166131657 hasConceptScore W2166131657C71924100 @default.
• W2166131657 hasConceptScore W2166131657C87355193 @default.
• W2166131657 hasIssue "5" @default.
• W2166131657 hasLocation W21661316571 @default.
• W2166131657 hasLocation W21661316572 @default.
• W2166131657 hasLocation W21661316573 @default.
• W2166131657 hasLocation W21661316574 @default.
• W2166131657 hasOpenAccess W2166131657 @default.
• W2166131657 hasPrimaryLocation W21661316571 @default.
• W2166131657 hasRelatedWork W1453075140 @default.
• W2166131657 hasRelatedWork W1964732206 @default.
• W2166131657 hasRelatedWork W1972615471 @default.
• W2166131657 hasRelatedWork W1996805144 @default.
• W2166131657 hasRelatedWork W2030147052 @default.
• W2166131657 hasRelatedWork W2097335631 @default.
• W2166131657 hasRelatedWork W2396951113 @default.
• W2166131657 hasRelatedWork W2404864060 @default.
• W2166131657 hasRelatedWork W3121073106 @default.
• W2166131657 hasRelatedWork W32066770 @default.
• W2166131657 hasVolume "164" @default.
• W2166131657 isParatext "false" @default.
• W2166131657 isRetracted "false" @default.
• W2166131657 magId "2166131657" @default.
• W2166131657 workType "article" @default.